Exposing The Truth About Peptides.

Vitality 40+
8 followers
Join me in continuing the fight against medical misinformation and changing the world.
#Vitality40Plus #HealthyOver40 #FitOver40 #Over40Health
AI Generated·May contain errors
Video Summary
AI GeneratedThis video examines the controversial rise of \"wellness peptides\" and a recent FDA advisory committee vote that recommended adding several unproven substances to the compounding bulks list. It highlights the dangerous tension between social media-driven demand, financial conflicts of interest within regulatory committees, and the necessity of rigorous scientific validation for patient safety.
My patients, my friends, even my loved ones
can't stop asking me about peptides.
They're all over the news, podcasts, and social media.
Two years ago, no one had even heard of peptides.
Now they're everywhere.
Imagine a tool that could speed up healing,
reduce inflammation, and build muscle.
How about peptides?
If you ever get injured, get immediately on BP-157 and TB-500.
For this video, I dove into the peptide research world,
spoke with leading experts,
and uncovered a truly shocking story
about this recent FDA vote on seven popular peptides
that seemingly slid completely under everyone's radar.
So stick around till the end of this video
to hear that story.
Let me explain what peptides are,
and perhaps more importantly, what they aren't.
Peptides are short chains of amino acids,
the same basic building blocks that make up proteins.
Naturally, the question here is,
if both are made up of amino acids,
how are peptides different from proteins?
Well, there's no universally agreed upon answer.
Peptides are generally smaller,
proteins are generally larger,
and often perform more complex functions.
But these are tendencies, not hard rules.
For our purposes, let's think of peptides
as chemical messengers in the body,
helping regulate processes such as metabolism,
inflammation, growth, and repair.
We can actually use insulin as an example.
It signals muscle and fat cells
to take up sugar from the bloodstream,
while telling the liver to store sugar
and release less of it.
This keeps blood sugar within an ideal range
and allows glucose to be used appropriately for energy.
We know this process extremely well,
because insulin has been extensively studied
in lab models, in animals, and more importantly, in humans.
This was all part of the extensive FDA regulatory review
that these drugs must go through
before being allowed to be considered
prescription drugs in the US.
But where did the rise of these newer peptides come from?
In the mid-20-teens, bodybuilders began experimenting
with peptides to give them an edge.
Then interest started to spread to the biohacker community.
By now, you've probably heard of peptides.
They've been a part of my biohacking practice
for a long time.
And the train fully hit its peak
once GLP-1 meds started consuming the media cycle,
giving many hope that perhaps peptides
truly harness the power to work for everything.
But getting these wellness peptides wasn't easy.
As in 2023, the FDA identified significant safety concerns
involving many compounded peptides,
so folks started to get creative.
Many began to obtain these wellness peptides
through telehealth, longevity or functional medicine clinics,
med spas, or even gray market websites,
selling them as research chemicals or not for human use.
This created a loophole where it seemed regulation
couldn't stop or catch up to them.
There were some clinics that arranged prescriptions
and shipments through compounding pharmacies,
but many online vendors often sold directly
without any medical supervision whatsoever.
While some of these were applied topically
or taken orally as capsules,
many were commonly supplied in vials
and self-injected under the skin.
That's right, people were injecting chemicals
into their bodies that had no regulatory review,
oversight, and were more likely than not
to be made abroad by questionable companies
with even more questionable contaminants.
To compare, the COVID vaccines were exponentially
more tested and scrutinized by scientists globally.
So if you felt the vaccines were rushed
or approved too soon, you should be outraged
at the fact that people are injecting themselves
with these peptides so prematurely.
What made this whole trend especially frustrating
is that celebrities couldn't stop going on podcasts,
sharing their stack and how well these peptides
were working for them.
I've been enjoying my peptides.
What is your stack of peptides?
NAD, ipamoralin and tesamoralin,
a Wolverine stack, and I'll tell you exactly what's in it.
I can never remember.
I love peptides.
ABC 1x7, MOTC, some-
I love MOTC.
MOTC's great.
Yeah, yeah.
So we have these understudied
and sometimes fully disproven compounds being promoted
with little we can do to discourage their use
because of the incredible push on social media.
It was almost as if they were creating a war
of information against doctors.
I saw this firsthand when I was asked a question
about peptides on Fox News.
A lot of people talk about injectable peptides.
They make promises like faster muscle healing,
tendon repair, gut health rejuvenation,
but we don't have the evidence to say that actually works.
My only goal was to highlight the fact
that we currently needed more evidence.
If a specific peptide becomes proven for a certain use
and a safety profile becomes established,
I would jump on the opportunity to discuss and promote them.
In fact, many of these same people who are anti-ozempic
and call doctors drug pushers
are the same ones mad at me
for wanting more safety data and treading carefully.
So the hypocrisy is real here.
It felt like the next series of events
should be rather straightforward.
Peptides will be studied for specific indications
in humans, safety data will be released,
and we will be able to recommend some of them
to patients for the right conditions.
But remember, RFK's in charge,
and before becoming HHS secretary,
he publicly promised to end the FDA's
aggressive suppression of peptides,
given he already personally used and believed in them.
I'm a big fan of peptides.
I've used them myself and used them with really good effect.
So he encouraged the PCAC,
the committee that advises the FDA
on issues related to compounded medications,
to conduct a new review of peptides.
Good morning, everybody.
It's 8 a.m., so let's get going.
Welcome.
But this wasn't an evaluation
on whether these peptides should be FDA approved.
The question, whether certain peptides,
including BPC-157 and TB-500,
should be added to the FDA's 503A bulks list,
which would allow compounding pharmacies
to legally make them for patients.
A compounding pharmacy makes customized medications,
like changing the dose, formulation, or ingredients,
when a standard FDA-approved product
doesn't meet a patient's needs.
That's really important,
because compounders sometimes need to make drugs
from raw bulk ingredients that have never been FDA approved,
and this list specifically outlines
which substances they're legally allowed to use.
However, just because a substance is on the bulks list
does not mean the FDA has approved it for everybody.
It means that a licensed pharmacist or physician
could use that substance to make a medication for a patient
without the drug going through
the typical FDA approval process.
This is supposed to support legitimate compounding
to help unique patient scenarios,
not serve as a shortcut to bypass a full review
by the FDA for general approval.
To decide whether a substance belongs on this list,
four questions are asked.
Can the substance be reliably identified and manufactured?
What safety concerns does it raise?
Is there evidence that it actually works?
Is there a meaningful history
of it being used in compounded medications?
For this meeting,
the committee was asked to review seven popular peptides.
BPC-157 for ulcerative colitis,
not tendon repair, muscle recovery,
or some Wolverine healing factors that you hear online.
KPV and TB500 for wound healing and inflammatory conditions.
MOTC for obesity and osteoporosis.
Then there were three less commonly discussed peptides,
amideltide, epitalon, and C-max.
Before the committee meets to vote,
FDA scientists are tasked with evaluating these compounds.
They spend months reviewing the chemistry,
the animal research, the available human data,
the proposed routes of administration,
and obviously the potential risks
of compounding each peptide.
What they found was rather startling.
Looking at BPC-157,
probably the most famous peptide in this scenario,
the agency found only one small human study
relevant to that use.
A meeting abstract, not a full study publication
involving 53 people
in which it was administered as an enema.
Rightfully, they considered it inadequate
to establish effectiveness or safety for ulcerative colitis.
Actually, the FDA found no randomized controlled human trials
establishing the safety or effectiveness
of injecting the peptide for tendon,
ligament, or muscle recovery.
For KPV, TB500, and MOTC,
the FDA reported that it could not identify
human exposure data at all.
Think about what this means for a second.
The scientists could not find any adequate
published evidence showing what happens
when the substances are administered to humans
in the first place.
Then there were the basic manufacturing questions.
Peptides can aggregate, degrade, trigger immune reactions,
or contain impurities.
And when a chemical is being synthesized,
shipped as a powder, reconstituted, and injected,
small differences in purity, storage, or formulation
can matter tremendously.
So even if an animal study uses something called BPC-157,
that does not guarantee that every vial being sold online,
or even every bulk ingredient delivered to a pharmacy,
is chemically identical to what was studied.
And this is obviously crucial.
Think about this for insulin.
Imagine you need 10 units injected
to control your blood sugar.
And when you go to inject a formulation,
it's such that you select 10, but end up getting 40 units,
and drop your sugar to a lethally low range.
Sounds awful, right?
Well, the FDA monitors and aims
to prevent that from happening.
So without surprise, the scientists made their reports,
and their conclusion was remarkably consistent.
They recommended against adding every single one of them
to the 503A bulks list.
All seven peptides got no recommendations.
Not because the scientists had proven
that every peptide was useless,
and not because they believed
all peptides were somehow dangerous.
Their position was rather simple.
The evidence wasn't strong enough
to confidently decide what patients would be receiving,
whether it would help them, what dose should be used,
or what harmful effects might happen.
Exact TB500 sequences can vary between vendors.
When you write a script for TB500,
what form do you think your patients are getting?
Does anybody know?
It feels like the story should end here,
but sadly it doesn't.
So the awaited public meeting began.
FDA scientists presented their analysis,
supporters and opponents gave testimony.
Committee members asked questions.
And after discussing each peptide,
the PCAC members voted on whether
to recommend adding it to the list.
The strongest argument from the pro-peptide side
wasn't that these substances had already
been conclusively proven to work or were safe.
They believed that it was harm reduction.
They argued that Americans were already buying
and injecting peptides regardless of what the FDA said.
They were ordering products from overseas suppliers,
social media sellers, and websites labeling them
as research chemicals.
Just last week, I had a patient whose research grade,
whatever that they got from someplace
that they brought to me to fix,
was laced with MDMA and ecstasy.
That's not protecting the American people.
So my yes comes from there.
Their argument was essentially that not including them
on the bulk list simply pushes that demand
towards an even less controlled gray market.
And I wanna be honest here, the argument is fairly logical.
If people are set on using an unproven substance,
obtaining it from a licensed pharmacy may be less dangerous
than injecting a mystery powder purchased online.
But it also isn't a question the approval process
is designed to answer.
It's supposed to tell us about the usefulness of the drug,
the safety of the drug,
and ideally how that drug should be made.
Then came the first major vote, BPC-157.
For the record, there are eight yeses,
six noes, and one abstention.
I would like to remind the observers
to please keep your applause to a minimum.
The committee had just voted to recommend BPC-157
over the opposition of the FDA scientists
who had performed the scientific review.
KPV and TB500 received the same eight supporting votes.
MOTC narrowly passed as well.
On the second day, Amideltide failed,
but Epitalon and C-Max passed.
By the end of the meeting,
the committee had recommended adding six
of the seven peptides to the bulks list,
despite the scientists recommending
against every one of them.
Now, this did not immediately legalize the peptides.
The committee functions in an advisory capacity.
Adding the substances to the actual list
would still require formal government action
and public rulemaking.
So podcast bros or clinics claiming
that BPC-157 is now FDA approved
or that the FDA declared it safe
are completely lying and full of ---- about what happened.
But one thing I want you to look into was how this happened.
Why did the scientists recommend against every single one
while the advisory committee voted
to recommend six of them?
Who was actually doing the voting?
This is where things start to look really shady.
Eight of the committee's 11 regular voting members
had begun their terms just weeks before the meeting.
The committee had essentially been rebuilt
right before it was considering one of RFK's pet projects.
Well, okay, maybe that's a coincidence, right?
You know, RFK always points out how conflicts of interest
would destroy the value of any health advisory committee.
It's imperative that we remove officials
with conflicts of interest
and catastrophically bad judgment and political agendas.
So the newly appointed members
had to be free of conflicts related to these peptides,
right?
Well, according to reports, FDA officials,
including Dr. Marty McCary,
actually raised concerns about potential conflicts,
but HHS moved forward with the selections anyway.
Oh, and as a reminder, later under threats of being fired,
Dr. McCary resigned.
Anyway, the newly appointed eight members included
owners and executives of regenerative medicine, longevity,
men's health, and personalized medicine clinics,
along with professionals connected to pharmacy
and compounding businesses.
Several independent reports
identified potential financial conflicts
involving these members
because their businesses operated in areas
that could benefit from expanded peptide access.
They basically worked at clinics that offered, promoted,
or operated in the same longevity marketplace
that stood to benefit
if the FDA permitted these substances to be compounded.
One member was actually a pharmacist
connected to a compounding pharmacy
and was also the son of representative Diana Harshbarger
who previously urged Kennedy
to convene a committee review of peptides.
And despite those concerns,
no conflict of interest waivers
explaining why these members were permitted to participate
were announced for the meeting.
Obviously, the voting pattern was not so shocking.
Every single pro-vote cast for any of the seven peptides
came from this group of eight new committee members.
Meanwhile, every preexisting expert on the panel
voted against or abstained from adding the peptides.
For BPC-157, KPV, and TB500,
the eight regular members voted yes as a group.
The FDA scientists recommended no,
but because the eight-member group formed the majority,
the recommendation passed anyway.
Look, I wish there was some groundbreaking research
that was uncovered
proving these peptides could help my patients,
but that's not what happened.
What was beginning to unfold
was a potentially new and dangerous shortcut
to get medications approved.
Instead of requiring companies to conduct trials
and earn approval for a specific medical use,
this shortcut could allow experimental substances
to reach patients without needing to prove safety,
efficacy, and quality.
This creates a really dangerous incentive.
A company may no longer need to spend time and money
studying a medication if influencers, clinics,
and online communities
can first create enormous consumer demand,
then point to that demand
as evidence that access is necessary.
Honestly, that process is ass-backward.
Instead of funding high-quality research
to back up their claims,
companies can start profiting from demand instead of proof.
For all the problems folks have
with the pharmaceutical industry,
at least they have to prove their medications work,
under what doses they work, and have a safety profile.
In this scenario,
we have the potential to get a worse version
of the pharma industry,
one where no proof is needed,
money is made hand over fist,
and corruption and conflict of interest runs amok.
But I guess that still leaves us
with the most important scientific question.
Could some of these peptides
eventually become useful medicines?
Maybe.
Insulin was once experimental.
Semaglutide was once experimental.
Every medication begins as an unproven hypothesis.
But a promising medication and podcast excitement
is only the beginning of the process,
and the huge majority of treatments
with mega-initial promise just don't pan out.
Remember the thalidomide fiasco
that caused birth defects galore?
Well, the reason it didn't come to the US
was because the FDA denied it.
Click here for that story,
and as always, stay happy and healthy.
